Bone Graft Substitute
Vitoss is a highly porous beta Tricalcium phosphate bone graft with clinical research demonstrating efficacy in a variety of anatomical locations.1 With over 375,000 implantations worldwide, Vitoss continues to be a leading synthetic bone graft.2 It’s available in a variety of forms, including, moldable pack, malleable strip and morsels.
- Open, interconnected structure designed to allow for 3D bone regeneration.3
- Vitoss is up to 90% porous, cancellous bone ranges from 70-90%.4
- Scaffold resorbs at a relevant timeframe during bone repair.5
- Forms of Vitoss containing Bioactive Glass are available.6
- Millennium Research Group: US Markets for Orthopedic Biomaterials 2016
- 5701-0002 Vitoss Bibliography
- Orthovita Test Report P/N 1050-0003R.
- Orthovita Test Report P/N 1070-0008R.
- Anker et al, Ultraporous Beta-Tricalcium Phosphate is Well Incorporated in Small Cavitary Defects. Clinical Orthopaedics and Related Research, 2005 May; 434: 251-7.
- Havener M, et al. ORS 2008. P1890.
Stryker Corporation or its divisions or other corporate affiliated entities own, use or have applied for the following trademarks or service marks: Stryker, Vitoss. All other trademarks are trademarks of their respective owners or holders.